中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Drug nanoclusters formed in confined nano-cages of CD-MOF: dramatic enhancement of solubility and bioavailability of azilsartan

文献类型:期刊论文

作者He, Yuanzhi1,2; Zhang, Wei2,3; Guo, Tao2; Zhang, Guoqing2; Qin, Wei1,2; Zhang, Liu2; Wang, Caifen2; Zhu, Weifeng1; Yang, Ming1; Hu, Xiaoxiao2
刊名ACTA PHARMACEUTICA SINICA B
出版日期2019
卷号9期号:1页码:97-106
关键词gamma-Cyclodextrin metal organic framework Nanoclusterization Azilsartan Mechanism Solubility Bioavailability Molecular modeling
ISSN号2211-3835
DOI10.1016/j.apsb.2018.09.003
通讯作者Wu, Li(track_wuly@163.com) ; Gref, Ruxandra(ruxandra.gref@u-psud.fr) ; Zhang, Jiwen(jwzhang@simm.ac.cn)
英文摘要Tremendous efforts have been devoted to the enhancement of drug solubility using nanotechnologies, but few of them are capable to produce drug particles with sizes less than a few nanometers. This challenge has been addressed here by using biocompatible versatile y-cyclodextrin (gamma -CD) metal-organic framework (CD-MOF) large molecular cages in which azilsartan (AZL) was successfully confined producing clusters in the nanometer range. This strategy allowed to improve the bioavailability of AZL in Sprague Dawley rats by 9.7-fold after loading into CD-MOF. The apparent solubility of AZL/CD-MOF was enhanced by 340-fold when compared to the pure drug. Based on molecular modeling, a dual molecular mechanism of nanoclusterization and complexation of AZL inside the CD-MOF cages was proposed, which was confirmed by small angle X-ray scattering (SAXS) and synchrotron radiation-Fourier transform infrared spectroscopy (SR-FTIR) techniques. In a typical cage-like unit of CD-MOF, three molecules of AZL were included by the gamma-CD pairs, whilst other three AZL molecules formed a nanocluster inside the 1.7 nm sized cavity surrounded by six gamma-CDs. This research demonstrates a dual molecular mechanism of complexation and nanoclusterization in CD-MOF leading to significant improvement in the bioavailability of insoluble drugs. (C) 2019 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
WOS关键词METAL-ORGANIC FRAMEWORKS ; DELIVERY ; STABILITY ; ENCAPSULATION ; NANOCRYSTALS ; FORMULATION ; CURCUMIN ; PHASE ; GEL
资助项目National Science and Technology Major Projects for the Major New Drugs Innovation and Development (China)[2018ZX09721002-009] ; Strategic Priority Research Program of Chinese Academy of Sciences[XDA12050307] ; National Natural Science Foundation of China[81430087] ; China Postdoctoral Science Foundation[2017M610284]
WOS研究方向Pharmacology & Pharmacy
语种英语
WOS记录号WOS:000457201700009
出版者INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES
源URL[http://119.78.100.183/handle/2S10ELR8/290616]  
专题中国科学院上海药物研究所
通讯作者Wu, Li; Gref, Ruxandra; Zhang, Jiwen
作者单位1.Jiangxi Univ Tradit Chinese Med, Key Lab Modern Preparat TCM, Minist Educ, Nanchang 330004, Jiangxi, Peoples R China
2.Chinese Acad Sci, Ctr Drug Delivery Syst, Shanghai Inst Mat Med, Shanghai 201210, Peoples R China
3.Shanghai Inst Technol, Sch Chem & Environm Engn, Shanghai 201418, Peoples R China
4.Univ Paris Saclay, Univ Paris Sud, UMR CNRS 8214, Inst Sci Mol Orsay, F-91400 Orsay, France
5.Yantai Univ, Sch Pharm, Key Lab Mol Pharmacol & Drug Evaluat, Minist Educ, Yantai 264005, Peoples R China
推荐引用方式
GB/T 7714
He, Yuanzhi,Zhang, Wei,Guo, Tao,et al. Drug nanoclusters formed in confined nano-cages of CD-MOF: dramatic enhancement of solubility and bioavailability of azilsartan[J]. ACTA PHARMACEUTICA SINICA B,2019,9(1):97-106.
APA He, Yuanzhi.,Zhang, Wei.,Guo, Tao.,Zhang, Guoqing.,Qin, Wei.,...&Zhang, Jiwen.(2019).Drug nanoclusters formed in confined nano-cages of CD-MOF: dramatic enhancement of solubility and bioavailability of azilsartan.ACTA PHARMACEUTICA SINICA B,9(1),97-106.
MLA He, Yuanzhi,et al."Drug nanoclusters formed in confined nano-cages of CD-MOF: dramatic enhancement of solubility and bioavailability of azilsartan".ACTA PHARMACEUTICA SINICA B 9.1(2019):97-106.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。